“종로립카페👨 ▷OPDAL020.컴◁오피달리기 🌖종로키스방💣종로스웨디시🚬종로마사지🈵종로대딸방👜종로풀싸롱👩종로대딸방😢”的搜索结果，显示 401-410 项，共有 10188 项

1. 内分泌科- 临床试验- 妙佑医疗国际

   Rochester, Minn. The purpose of this study is to evaluate whether or not semaglutide can slow down the growth and worsening of chronic kidney disease in people ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   以下为当前的临床试验。 ... （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Effects of Cognitive Function, Post-op ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Study B9991011 is a multi-center, international, randomized, open label, 2 component (Phase 1b followed by Phase 3), parallel-arm study of avelumab in ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   以下为当前的临床试验。 ... （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Effects of Cognitive Function, Post-op ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and effectiveness of CapsoCam® Colon (CV-3) endoscope system for the detection of colonic polyps.

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This phase I trial evaluates the safety, effectiveness, and best dose of onvansertib for the treatment of patients with chronic myelomonocytic leukemia that ...

8. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This open-label, randomized study will compare the efficacy of GDC-0199 plus rituximab (GDC-0199+R) with bendamustine plus MabThera/Rituxan ( ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The primary objective of the study is to compare sacituzumab tirumotecan combined with pembrolizumab to pembrolizumab alone with respect to overall survival ...

10. 胃肠病科和肝病科- 临床试验- 妙佑医疗国际

    Rochester, Minn. About this study. Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public ...